[TNGX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
09-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -336.01%
YoY- 26.91%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 5,771 5,758 5,716 6,787 18,153 6,386 9,142 -26.47%
PBT -24,855 -25,208 -21,869 -19,528 -4,514 -12,032 -8,864 99.22%
Tax 3 -171 177 62 -21 74 0 -
NP -24,858 -25,037 -22,046 -19,590 -4,493 -12,106 -8,864 99.24%
Tax Rate - - - - - - - -
Total Cost 30,629 30,795 27,762 26,377 22,646 18,492 18,006 42.63%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -430.74 -434.82 -385.69 -288.64 -24.75 -189.57 -96.96 170.97%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.28 -0.29 -0.25 -0.28 -0.05 -0.14 -0.53 -34.72%
EPS Diluted -0.28 -0.29 -0.25 -0.28 -0.05 -0.14 -0.42 -23.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.